当前位置:首页 - 行情中心 - 瑞康医药(002589) - 财务分析

瑞康医药

(002589)

  

流通市值:31.96亿  总市值:41.38亿
流通股本:11.62亿   总股本:15.05亿

瑞康医药(002589)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.28亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益569603.21万元,未分配利润29956.66万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1742754.49万元,负债1173151.28万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入6,105,062,530.674,079,932,498.772,073,027,669.1612,311,277,753.66
营业总成本6,210,217,250.064,183,994,764.222,081,916,966.4712,623,185,403.65
营业利润51,104,126.2464,831,982.9932,977,740.71-1,716,619,257.72
利润总额33,260,792.1667,104,416.5732,936,581.69-1,743,911,564.01
净利润27,832,019.641,586,431.7529,983,448.04-1,739,472,653.43
其他综合收益----
综合收益总额27,832,019.641,586,431.7529,983,448.04-1,739,472,653.43
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计12,144,597,274.4713,177,362,317.5813,947,004,834.9812,819,555,974.53
非流动资产合计5,282,947,631.145,103,847,606.985,242,855,503.145,511,518,672.29
资产总计17,427,544,905.6118,281,209,924.5619,189,860,338.1218,331,074,646.82
流动负债合计11,516,621,579.8412,332,943,622.6613,331,769,405.5712,468,436,548.57
非流动负债合计214,891,203.48157,446,860.768,217,523.17110,830,969.74
负债合计11,731,512,783.3212,490,390,483.3613,399,986,928.7412,579,267,518.31
归属于母公司股东权益合计5,483,430,853.835,488,920,354.585,437,030,036.745,407,787,638.68
股东权益合计5,696,032,122.295,790,819,441.25,789,873,409.385,751,807,128.51
负债和股东权益合计17,427,544,905.6118,281,209,924.5619,189,860,338.1218,331,074,646.82
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计7,277,559,775.644,726,858,999.662,428,371,185.8115,276,717,833.44
经营活动现金流出小计6,945,064,730.174,548,178,385.612,352,780,522.4114,753,643,959.03
经营活动产生的现金流量净额332,495,045.47178,680,614.0575,590,663.4523,073,874.41
投资活动现金流入小计1,041,094,767.33840,754,044.3367,177,087.792,531,785,150.53
投资活动现金流出小计601,319,156.37264,628,288.93119,464,778.891,938,827,766.52
投资活动产生的现金流量净额439,775,610.96576,125,755.37247,712,308.9592,957,384.01
筹资活动现金流入小计15,528,940,865.2311,572,396,002.486,399,566,227.1817,498,435,310.32
筹资活动现金流出小计16,356,808,464.3811,919,233,966.526,341,584,195.5418,963,560,415.12
筹资活动产生的现金流量净额-827,867,599.15-346,837,964.0457,982,031.64-1,465,125,104.8
汇率变动对现金及现金等价物的影响---4,016.01
现金及现金等价物净增加额-55,596,942.72407,968,405.38381,285,003.94-349,089,830.37
期末现金及现金等价物余额431,546,196.65895,111,544.75868,428,143.31487,143,139.37
TOP↑